Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assia Samri

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|March 7, 2013
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infectionGuillemette Antoni, Julien Guergnon, Céline Meaudre, et al.
AIDS (London, England)|August 31, 2010
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus controlJing Xie, Wei Lu, Assia Samri, et al.
AIDS (London, England)|December 22, 2021
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adultsChristine Durier, Séverine Mercier-Delarue, Nathalie Colin De Verdière, et al.
AIDS (London, England)|October 22, 2010
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patientsAna Canestri, Anne Krivine, Lambert Assoumou, et al.
AIDS (London, England)|May 12, 2017
Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individualsMorgane Griesbeck, Marc-Antoine Valantin, Karine Lacombe, et al.
AIDS Research and Human Retroviruses|October 14, 2020
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected NonprogressorsMariama Sadjo Diallo, Assia Samri, Charlotte Charpentier, et al.
Immunology Letters|September 17, 2025
Coordination of cellular responses to SARS-CoV-2 during severe COVID-19 illnessAssia Samri, Raphael Lhote, Alice Rousseau, et al.
Retrovirology|April 9, 2005
First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections"Elisabeth Menu, Mickaela C Müller-Trutwin, Gianfranco Pancino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|March 7, 2013
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infectionGuillemette Antoni, Julien Guergnon, Céline Meaudre, et al.
AIDS (London, England)|August 31, 2010
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus controlJing Xie, Wei Lu, Assia Samri, et al.
AIDS (London, England)|December 22, 2021
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adultsChristine Durier, Séverine Mercier-Delarue, Nathalie Colin De Verdière, et al.
AIDS (London, England)|October 22, 2010
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patientsAna Canestri, Anne Krivine, Lambert Assoumou, et al.
AIDS (London, England)|May 12, 2017
Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individualsMorgane Griesbeck, Marc-Antoine Valantin, Karine Lacombe, et al.
AIDS Research and Human Retroviruses|October 14, 2020
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected NonprogressorsMariama Sadjo Diallo, Assia Samri, Charlotte Charpentier, et al.
Immunology Letters|September 17, 2025
Coordination of cellular responses to SARS-CoV-2 during severe COVID-19 illnessAssia Samri, Raphael Lhote, Alice Rousseau, et al.
Retrovirology|April 9, 2005
First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections"Elisabeth Menu, Mickaela C Müller-Trutwin, Gianfranco Pancino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Pageof 7